Loading...

WuXi Biologics (Cayman) Inc.

WXXWYPNK
HealthcareBiotechnology
$6.43
$0.13(2.06%)

WuXi Biologics (Cayman) Inc. WXXWY Peers

See (WXXWY) competitors and their performances in Stock Market.

Peer Comparison Table: Biotechnology Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

SymbolPriceChange %Market CapP/E RatioEPSDividend Yield
WXXWY$6.43+2.06%13.1B29.23$0.22N/A
NONOF$75.61+3.43%335.6B21.18$3.57+2.20%
CSLLY$79.06-0.02%153.1B28.96$2.73+1.67%
CMXHF$151.50-4.36%73.4B27.85$5.44+1.83%
UCBJY$92.77-0.18%35.8B29.83$3.11+0.85%
ARGNF$562.00N/A34.3B34.25$16.41N/A
UCBJF$179.39N/A34.1B28.84$6.22+0.88%
ODTC$22,005.00+29.44%24.1B-0.08-$268,995.00N/A
IVBXF$9.26-2.53%15.3B-926.00-$0.01N/A
GNMSF$218.13+2.89%13.4B12.80$17.04N/A
Showing 1 to 10 of 100 results
1

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

WXXWY vs NONOF Comparison

WXXWY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, WXXWY stands at 13.1B. In comparison, NONOF has a market cap of 335.6B. Regarding current trading prices, WXXWY is priced at $6.43, while NONOF trades at $75.61.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

WXXWY currently has a P/E ratio of 29.23, whereas NONOF's P/E ratio is 21.18. In terms of profitability, WXXWY's ROE is +0.06%, compared to NONOF's ROE of +0.81%. Regarding short-term risk, WXXWY is less volatile compared to NONOF. This indicates potentially lower risk in terms of short-term price fluctuations for WXXWY.

Stock Price Comparison

Loading...

Frequently Asked Questions